STANFORD UNIVERSITY
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1885-11-11
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.stanford.edu
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Recruiting
- Conditions
- First Posted Date
- 2006-11-10
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 9999
- Registration Number
- NCT00398177
- Locations
- ๐บ๐ธ
Stanford University School of Medicine, Stanford, California, United States
Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CA
Not Applicable
Terminated
- Conditions
- First Posted Date
- 2006-11-01
- Last Posted Date
- 2010-03-29
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 15
- Registration Number
- NCT00394615
- Locations
- ๐บ๐ธ
Stanford University School of Medicine, Stanford, California, United States
Imaging Study of Chronic Low Back Pain in Patients Taking Pain Medication
- First Posted Date
- 2006-10-16
- Last Posted Date
- 2017-12-11
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 14
- Registration Number
- NCT00388414
- Locations
- ๐บ๐ธ
Stanford University School of Medicine, Stanford, California, United States
Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-10-16
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 146
- Registration Number
- NCT00388349
- Locations
- ๐บ๐ธ
Stanford University School of Medicine, Stanford, California, United States
Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease
- First Posted Date
- 2006-10-16
- Last Posted Date
- 2017-04-21
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 36
- Registration Number
- NCT00388362
- Locations
- ๐บ๐ธ
Stanford University School of Medicine, Stanford, California, United States
Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2
Completed
- Conditions
- First Posted Date
- 2006-10-03
- Last Posted Date
- 2013-05-30
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 30
- Registration Number
- NCT00383604
- Locations
- ๐บ๐ธ
Stanford University School of Medicine, Stanford, California, United States
A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer
Phase 2
Terminated
- Conditions
- First Posted Date
- 2006-10-03
- Last Posted Date
- 2013-01-28
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 20
- Registration Number
- NCT00383487
- Locations
- ๐บ๐ธ
Stanford University School of Medicine, Stanford, California, United States
Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia.
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-10-03
- Last Posted Date
- 2017-06-01
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 48
- Registration Number
- NCT00383643
- Locations
- ๐บ๐ธ
Stanford University School of Medicine, Stanford, California, United States
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-10-03
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 75
- Registration Number
- NCT00383500
- Locations
- ๐บ๐ธ
Stanford University School of Medicine, Stanford, California, United States
Effect of Behavior Therapy on Responses to Social Stimuli in People With Social Phobia
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-09-26
- Last Posted Date
- 2011-11-30
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 124
- Registration Number
- NCT00380731
- Locations
- ๐บ๐ธ
Stanford University, Stanford, California, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath